Krebs Andreasinsider trades

In SEC Form 4 filings, Krebs Andreas is listed as Director of Definium Therapeutics, Inc. (DFTX). Krebs Andreas reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 18.

Companies and roles

Company	Role	Transactions	Last filed
DFTXDefinium Therapeutics, Inc.	Director	2	Sep 18

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-18

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
DFTXDefinium Therapeutics, Inc.	Sep 18	Sep 18	M	1,629	$35.52	$57,862	21,402	No	Form 4
DFTXDefinium Therapeutics, Inc.	Sep 18	Sep 18	M · derivative	1,629	$35.52	$57,862	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.